Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-10 08:00 |
Valneva annonce la publication de son Document d’Enregistrement Universel 2020 …
|
French | 393.3 KB | ||
| 2021-04-10 08:00 |
Valneva Files Registration Statement for Proposed United States Initial Public …
|
English | 133.3 KB | ||
| 2021-04-09 19:08 |
Document d'enregistrement universel 2020
|
French | 7.8 MB | ||
| 2021-04-06 07:00 |
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-1…
|
English | 589.9 KB | ||
| 2021-04-06 07:00 |
Valneva annonce des résultats positifs de Phase 1/2 pour son candidat vaccin in…
|
French | 601.7 KB | ||
| 2021-04-02 18:00 |
Valneva - Déclaration d’actions et de droits de vote – Mars 2021
|
English | 205.0 KB | ||
| 2021-03-24 07:00 |
Valneva annonce la publication de ses comptes consolidés et audités pour l’exer…
|
French | 385.0 KB | ||
| 2021-03-24 07:00 |
Valneva Publishes its FY 2020 Audited Consolidated Financial Statements
|
English | 299.7 KB | ||
| 2021-03-22 07:00 |
Valneva entre dans le SBF 120 et le CAC Mid 60 d’Euronext
|
French | 388.4 KB | ||
| 2021-03-22 06:00 |
Valneva Joins Euronext SBF 120 and CAC Mid 60 Indices
|
English | 303.6 KB | ||
| 2021-03-18 14:25 |
Franchissement de seuil
|
French | 195.0 KB | ||
| 2021-03-13 08:45 |
Valneva Announces Supervisory Board Changes
|
English | 425.9 KB | ||
| 2021-03-13 08:45 |
Valneva annonce un changement au sein de son Conseil de Surveillance
|
French | 428.5 KB | ||
| 2021-03-08 07:00 |
Valneva et Pfizer annoncent l’initiation d’un essai de Phase 2 pour leur candid…
|
French | 755.4 KB | ||
| 2021-03-08 07:00 |
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccin…
|
English | 740.7 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
